# EDGAR Filing Document

**Accession Number:** 0001419248
**File Stem:** 0001290929-23-000001
**Filing Date:** 2023-1
**Character Count:** 7509
**Document Hash:** d4919d6ed7ea4ffa794992da6be5ccd0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001290929-23-000001.hdr.sgml**: 20230109

**ACCESSION NUMBER**: 0001290929-23-000001

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221028

**FILED AS OF DATE**: 20230109

**DATE AS OF CHANGE**: 20230109

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wolf James G.
- **CENTRAL INDEX KEY:** 0001419248

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-09974
- **FILM NUMBER:** 23517786

**MAIL ADDRESS:**
- **STREET 1:** 105, FLYWAY DRIVE
- **CITY:** KIAWAH ISLAND
- **STATE:** SC
- **ZIP:** 29455
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ENZO BIOCHEM INC
- **CENTRAL INDEX KEY:** 0000316253
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **IRS NUMBER:** 132866202
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 0731

**BUSINESS ADDRESS:**
- **STREET 1:** 60 EXECUTIVE BLVD
- **CITY:** FARMINGDALE
- **STATE:** NY
- **ZIP:** 11735
- **BUSINESS PHONE:** 5167555500

**MAIL ADDRESS:**
- **STREET 1:** ENZO BIOCHEM INC
- **STREET 2:** 60 EXECUTIVE BLVD
- **CITY:** FARMINGDALE
- **STATE:** NY
- **ZIP:** 11735

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wolf James G.<br><sub>(Last) (First) (Middle)</sub><br>105, FLYWAY DRIVE<br><sub>(Street)</sub><br>KIAWAH ISLAND, SC 29455<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>ENZO BIOCHEM INC [ ENZ ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2022-10-28 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock, $0.01 par value | 3560000 | D |  |
| Common Stock, $0.01 par value | 116000 | I | See Footnote <sup>(1)(1)</sup> |
| Common Stock, $0.01 par value | 22000 | I | See Footnote <sup>(2)(2)</sup> |
| Common Stock, $0.01 par value | 110000 | I | See Footnote <sup>(3)(3)</sup> |
| Common Stock, $0.01 par value | 170500 | I | See Footnote <sup>(4)(4)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Long Call Option (right to buy) | 2022-10-28<sup>(5)</sup> | 2023-01-20 | Common Stock | 275000 | $2.5 | D |  |
| Long Call Option (right to buy) | 2022-10-28<sup>(5)</sup> | 2023-01-20 | Common Stock | 200000 | $5 | D |  |
| Long Call Option (right to buy) | 2022-10-28<sup>(5)</sup> | 2023-04-21 | Common Stock | 75000 | $2.5 | D |  |
| Long Call Option (right to buy) | 2022-10-28<sup>(5)</sup> | 2023-04-21 | Common Stock | 80700 | $5 | D |  |
| Long Call Option (right to buy) | 2022-10-28<sup>(5)</sup> | 2023-04-21 | Common Stock | 75000 | $7.5 | D |  |
| Short Put Option (obligation to buy) | 2022-10-28<sup>(6)</sup> | 2023-01-20 | Common Stock | 400000 | $2.5 | D |  |
| Short Put Option (obligation to buy) | 2022-10-28<sup>(6)</sup> | 2023-01-20 | Common Stock | 34500 | $5 | D |  |
| Short Put Option (obligation to buy) | 2022-10-28<sup>(6)</sup> | 2023-04-21 | Common Stock | 30000 | $2.5 | D |  |

---

### Footnotes:

(1) These shares are held in qualified retirement accounts in the name, and for the benefit of, the Reporting Person.

(2) These shares are held in a qualified retirement account in the name, and for the benefit, of the Reporting Person's spouse. The Reporting Person has dispositive and voting control over the retirement account. The Reporting Person disclaims beneficial ownership of the securities held by this retirement account, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

(3) These shares are held directly by the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

(4) These shares are held directly by the Reporting Person's adult children, each holding a portion of the shares individually. The Reporting Person maintains powers of attorney granted by each of his adult children with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his adult children. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

(5) Each call option may be exercised from the date it was purchased through the expiration date of the call option.

(6) Each put option may be exercised by the owner of the option at any time from the date of its sale through the expiration date of the put option.

**Signature:** James G. Wolf  
**Date:** 2023-01-09

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**